These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15383587)

  • 1. Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5.
    Thai CT; Ogata RT
    J Immunol; 2004 Oct; 173(7):4547-52. PubMed ID: 15383587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
    Thai CT; Ogata RT
    J Immunol; 2003 Dec; 171(12):6565-73. PubMed ID: 14662858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT; Ogata RT
    J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional insights from the structure of the multifunctional C345C domain of C5 of complement.
    Bramham J; Thai CT; Soares DC; Uhrín D; Ogata RT; Barlow PN
    J Biol Chem; 2005 Mar; 280(11):10636-45. PubMed ID: 15598652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of factor I-like modules from complement C7 reveals a pair of follistatin domains in compact pseudosymmetric arrangement.
    Phelan MM; Thai CT; Soares DC; Ogata RT; Barlow PN; Bramham J
    J Biol Chem; 2009 Jul; 284(29):19637-49. PubMed ID: 19419965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
    Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
    Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6.
    Haefliger JA; Tschopp J; Vial N; Jenne DE
    J Biol Chem; 1989 Oct; 264(30):18041-51. PubMed ID: 2808363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of the factor I modules (FIMS) of human complement component C6.
    DiScipio RG; Linton SM; Rushmere NK
    J Biol Chem; 1999 Nov; 274(45):31811-8. PubMed ID: 10542204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of the C6A form cDNA of the mouse sixth complement component: functional integrity despite the absence of factor I modules.
    Yu JX; Bradt BM; Cooper NR
    Immunogenetics; 2000 Aug; 51(10):779-87. PubMed ID: 10970092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic bead based assays for complement component C5.
    DiScipio RG; Schraufstatter IU
    J Immunol Methods; 2017 Nov; 450():50-57. PubMed ID: 28757372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
    Yamamoto KI
    J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.
    Mondragón-Palomino M; Piñero D; Nicholson-Weller A; Laclette JP
    J Mol Evol; 1999 Aug; 49(2):282-9. PubMed ID: 10441679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and structure of the C5b-7 complex of the lytic pathway of complement.
    DiScipio RG
    J Biol Chem; 1992 Aug; 267(24):17087-94. PubMed ID: 1387399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane attack by complement.
    Podack ER; Tschopp J
    Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.